|
著者・共著者 |
発行年月 |
表題 |
掲載誌名 |
掲載誌名 略称 |
巻号頁 |
1 | 海上耕平†*, 小木曽智美, 平間崇, 大木里花子, 別府寛子, 石渡亜由美, 内田啓子 | 2022/02 | 生体移植におけるドナー管理 | 移植 | | 56(4):363-370 |
2 | Ishihara H, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Takagi T, Iizuka J, Ishida H, Kondo T, Tanabe K. | 2022 | Prognostic Impact of Trial-Eligibility Criteria in Patients with Metastatic Renal Cell Carcinoma | Urol Int. | | 106(4):368-375 |
3 | 吉田 一彦 | 2022 | RAPN 困難症例に対する術式選択:開腹?ロボット?腎摘?
2.当院における高難度症例(high complex tumor)に対するロボット支援腎部分切除術の成績 | 泌尿器外科 | | 35(臨増), 791 〜 792 |
4 | NEMOTO Yuki†, ISHIHARA Hiroki*, NAKAMURA Kazutaka, TACHIBANA Hidekazu, FUKUDA Hironori, YOSHIDA Kazuhiko, KOBAYASHI Hirohito, IIZUKA Junpei, SHIMMURA Hiroaki, HASHIMOTO Yasunobu, TANABE Kazunari, KONDO Tsunenori, TAKAGI Toshio | 2022/01 | Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma. | International urology and nephrology | Int Urol Nephrol | 54(1):47-54 |
5 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2022/01 | Two laparotomy surgeries to achieve hemostasis after kidney transplantation in a patient with frailty: a case report. | Transplantation proceedings | Transplant Proc | 54(1):120-122 |
6 | Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Nishioki HI, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/1 | Association Between Anesthetic Technique and Survival After Radical Nephroureterectomy: A Propensity Score-matching Study. | IN VIVO | | 36(1):458-464 |
7 | Nemoto Y, Ishihara H, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2022/1 | Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma. | Int Urol Nephrol | | 54(1):47-54 |
8 | KANZAWA Taichi†, TOKITA Daisuke*, SAIGA Kan*, YAMAKAWA Takafumi, ISHIGOOKA Hidetoshi, FUKUDA Hironori, KATSUMATA Haruki, MIYAIRI Satoshi, ISHII Rumi, HIRAI Toshihito, IMAI Toshio, OKUMI Masayoshi, TANABE Kazunari | 2022/02 | Role of fractalkine-CX3CR1 axis in acute rejection of mouse heart allografts subjected to ischemia reperfusion injury | Transplant International | Transpl Int | 36:1-10 |
9 | TACHIBANA Hidekazu†*, NEMOTO Yuki, ISHIHARA Hiroki, FUKUDA Hironori, YOSHIDA Kazuhiko, IIZUKA Junpei, HASHIMOTO Yasunobu, KONDO Tsunenori, TANABE Kazunari, TAKAGI Toshio | 2022/02 | Predictive impact of early changes in serum C-reactive protein levels in nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma. | Clinical genitourinary cancer | Clin Genitourin Cancer | 20(1):e81-e88 |
10 | Tachibana H, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Kondo T, Tanabe K, Takagi T | 2022/2 | Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma. | Clin Genitourin Cancer | | 20(1):e81-e88. |
11 | 石原弘喜†, 長嶋洋治, 近藤恒徳, 高木敏男 | 2022/03 | 透析腎癌の遺伝子解析 | Urology Today | Urol Today | 29(1):11-17 |
12 | SHIMIZU Tomokazu†*, KATO Shinya, KIJIMA Yu, IWAMOTO Kana, HORIUCHI Toshihide, IIDA Shoichi, OMOTO Kazuya, INUI Masashi, NOZAKI Taiji, TOMA Hiroshi | 2022/03 | Japanese single-center experience of kidney transplant: Experience in a Japanese private hospital. | Transplantation proceedings | Transplant Proc | 54(2):282-285 |
13 | HATA Keisuke†*, ISHIDA Hideki, ISHIZUKA Kiyonobu, UNAGAMI Kohei, KANZAWA Taichi, OMOTO Kazuya, SHIMIZU Tomokazu, MIURA Kenichiro, HATTORI Motoshi, TANABE Kazunari | 2022/03 | Safe Renal Transplantation to the Extraperitoneal Cavity in Children Weighing Less Than 15 kg. | Transplantation proceedings | Transplant Proc | 54(2):248-253 |
14 | T. Kondo | 2022/3 | Is tailored systemic therapy in renal cell carcinoma realistic? Äb0 | Lancet Oncol | | 23:555-7. |
15 | Nakajima N, Miyajima A, Shinohara N, Obara W, Kondo T, Kimura G, Kume H, Fujimoto H, Sugiyama T, Nonomura N, Hongo F, Fukumori T, Takahashi M, Kanayama HO, Eto M | 2022/3 | Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association. | Jpn J Clin Oncol | | 52(3):274-280 |
16 | Yoshida K, Hata K, Iizuka J, Kondo T, Ishihara H, Ishida H, Nagashima Y, Tanabe K, Takagi T | 2022/3 | Immune Checkpoint Inhibitor Combination Therapy for Renal Cell Carcinomas With Concomitant Inferior Vena Cava Thrombi. | IN VIVO | | 36(2):1030-1034 |
17 | Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Yoshida K, Takagi T, Iizuka J, Tanabe K | 2022/3 | Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus. | Urol Oncol | | 40(3):110.e11-110.e18 |
18 | 巴 ひかる | 2022/3 | 学会好事 第15回PPCS学術集会 | Urology Today | | 29(1):52-52 |
19 | 巴 ひかる | 2022/3 | 特集 Female Urologyの蘊奥 積み重ねられた知恵と技術の活かし方 「企画にあたって」 | 臨床泌尿器科 | | 76(3):173-173 |
20 | 高木敏男 | 2022/3 | 移植患者における癌発生の疫学と特徴 | 腎と透析 | | 92 (3): 538-542 |
21 | 神澤太一†, 田邉一成 | 2022/04 | 定型的血管操作&吻合法 | 腎移植・血管外科 | | 32(1):8-13 |
22 | 吉田 一彦、高木敏男 | 2022/4 | IO時代における転移性腎癌に対する局所治療を考える
免疫チェックポイント阻害剤時代におけるdeffered cytoreductive nephrectomy | 泌尿器外科 | | 36(2), 106 〜 112 |
23 | ISHIDA Hideki†*, FURUSAWA Miyuki, UNAGAMI Kohei, OMOTO Kazuya, IIZUKA Junpei, TAKAGI Toshio | 2022/05 | Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: A retrospective cohort study at a single transplant institute in Japan. | Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation | Exp Clin Transplant | 20(5):463-471 |
24 | OKI Rikako†, UNAGAMI Kohei*, TANEDA Sekiko, TAKAGI Toshio, ISHIDA Hideki | 2022/05 | Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature. | Journal of nephrology | J Nephrol | 35(4):1289-1293 |
25 | 近藤恒徳 | 2022/5 | 鏡視下手術時代におけるリンパ節郭清の意義 | 臨床泌尿器科 | | 76(6)380-385 |
26 | Toguchi M, Kondo T, Yoshida K, Tanabe K, Takagi T. | 2022/5 | Perioperative outcomes following robot-assisted partial nephrectomy for renal cell carcinoma according to surgeon generation. | BMC Surg | | 26;22(1):205 |
27 | Ishiyama Y, Kondo T, Ishihara H, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/5 | C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery.I | J Robot Surg | | 16(3):649-654 |
28 | Wada A, Omae K, Yoshida K, Kondo T, Tanabe K, Takagi T | 2022/5 | Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre study. | Jpn J Clin Oncol | | 52(5):499-505 |
29 | Ishihara H, Nemoto Y, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2022/5 | Changes in Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma from the Molecular-Targeted Therapy Era to the Immune Checkpoint Inhibitor Era. | Target Oncol | | 17(3):307-319 |
30 | Nakajima N, Miyajima A, Shinohara N, Obara W, Kondo T, Kimura G, Kume H, Fujimoto H, Sugiyama T, Nonomura N, Hongo F, Fukumori T, Takahashi M, Kanayama HO, Eto M | 2022/5 | Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association. | Jpn J Clin Oncol | | 52(3):274-280 |
31 | Yudai Ishiyama 1 2, Tsunenori Kondo 3, Hiroki Ishihara 1, Kazuhiko Yoshida 2, Junpei Iizuka 2, Kazunari Tanabe 2, Toshio Takagi 2 | 2022/5 | C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery | Int J Clin Oncol | | 27(5):969-976 |
32 | TACHIBANA Hidekazu†, KONDO Tsunenori, ISHIYAMA Yudai, YOSHINO Maki, YOSHIDA Kazuhiko, IIZUKA Junpei, TANABE Kazunari, TAKAGI Toshio | 2022/06 | New longitudinal component of the RENAL nephrometry score for predicting the operative complexity in transperitoneal robot-assisted partial nephrectomy. | Journal of endourology / Endourological Society | J Endourol | 36(6):762-769 |
33 | YAGISAWA Takafumi†, TAKAGI Toshio*, YOSHIDA Kazuhiko, HATA Keisuke, IIZUKA Junpei*, MUROMIYA Yasuto, KONDO Tsunenori, TANABE Kazunari | 2022/06 | Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. | Journal of robotic surgery. | | 16(3):649-654 |
34 | Yagisawa T, Takagi T, Yoshida K, Hata K, Iizuka J, Muromiya Y, Kondo T, Tanabe K | 2022/6 | Surgical outcomes of robot-assisted laparoscopic partial nephrectomy for cystic renal cell carcinoma. | J Robot Surg | | 16(3):649-654 |
35 | Tachibana H, Inakawa T, Nemoto Y, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Hashimoto Y, Tanabe K, Kondo T, Takagi T. | 2022/6 | Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment. | Anticancer Res | | 42(6):3151-3158 |
36 | Ishiyama Y, Kondo T, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/6 | Thrombus-first or "thrombus-last" approach for surgical management of renal cell carcinoma with inferior vena cava thrombus. | Int J Urol | | 29(6):559-565 |
37 | Tachibana H, Omae K, Ishihara H, Fukuda H, Yoshida K, Iizuka J, Tanabe K, Kondo T, Takagi T | 2022/06 | Validation of a Predictive Model for New Baseline Renal Function After Radical Nephrectomy or Robot-Assisted Partial Nephrectomy in Japanese Patients. | J Endourol | | 36(6):745-751 |
38 | Tachibana H, Kondo T, Ishiyama Y, Yoshino M, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/6 | New Longitudinal Component of the RENAL Nephrometry Score for Predicting the Operative Complexity in Transperitoneal Robot-Assisted Partial Nephrectomy. | J Endourol | | 36(6):762-769 |
39 | 巴 ひかる | 2022/6 | プラタナス~私のカルテから~「右足でボールが受けられません」 | 週間 日本医事新報 | | (5120):3-3 |
40 | 巴 ひかる | 2022/6 | Ⅲ.高齢者良性泌尿器疾患の病態と治療 尿失禁・骨盤臓器脱 | 日本臨牀 特集 高齢者の泌尿器疾患update-病態に基づく診断・治療上の問題点- | | 80(6):965-971 |
41 | 巴 ひかる | 2022/6 | 特集 下部尿路機能障害(排尿障害)へのアプローチ 「間質性膀胱炎」 | 診断と治療 | | 110(6):771-776 |
42 | 長嶋洋治†*、池口歩美、稲垣茉里子、高木敏男 | 2022/07 | 腎細胞癌の病理診断 | Rinsho byori. The Japanese journal of clinical pathology | Rinsho Byori | 70(6):537-542 |
43 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, KANO Kana, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2022/07 | A case report of COVID-19 infection after kidney transplantation treated with casirivimab-imdevimab and mycophenolate mofetil changed to everolimus. | Transplantation proceedings | Transplant Proc | 54(6):1561-1563 |
44 | KIJIMA Yu†*, SHIMIZU Tomokazu, SEKIDO Eri, KATO Shinya, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2022/07 | Allogeneic kidney transplantation after COVID-19: A case report. | Transplantation proceedings | Transplant Proc | 54(6):1551-1553 |
45 | KIJIMA Yu†*, SHIMIZU Tomokazu, KATO Shinya, SEKIDO Eri, KANO Kana, TOGUCHI Makoto, HORIUCHI Toshihide, NOZAKI Taiji, OMOTO Kazuya, INUI Masashi, TOMA Hiroshi, IIDA Shoichi, TAKAGI Toshio | 2022/07 | Suspected pneumonia caused by coronavirus disease 2019 after kidney transplantation: A case report. | Transplantation proceedings | Transplant Proc | 54(6):1547-1550 |
46 | ISHIHARA Hiroki†*, NEMOTO Yuki, TACHIBANA Hidekazu, FUKUDA Hironori, YOSHIDA Kazuhiko, KOBAYASHI Hirohito, IIZUKA Junpei, HASHIMOTO Yasunobu, TAKAGI Toshio, ISHIDA Hideki, KONDO Tsunenori, TANABE Kazunari | 2022/07 | Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. | Japanese journal of clinical oncology | Jpn J Clin Oncol | 52(7):785-790 |
47 | Nishimura K, Ishihara H, Kondo T, Toguchi M, Fukuda H, Tachibana H, Toki D, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/7 | Assessment of Feasibility of Robot-assisted Radical Cystectomy in Patients With Advanced Bladder Cancer Treated With Maintenance Hemodialysis Therapy. | IN VIVO | | 36(4):1801-1806 |
48 | Nemoto Y, Ishihara H, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2022/7 | Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria. | Target Oncol | | 17(4):475-482 |
49 | Yoshida K, Kondo T, Iizuka J, Fukuda H, Ishihara H, Kobayashi H, Okumi M, Ishida H, Tanabe K, Takagi T | 2022/7 | Surgical and functional outcomes of robot-assisted laparoscopic partial nephrectomy for renal cell carcinoma in adolescents and young adults: a propensity score matching study. | Int J Clin Oncol | | 27(10):1624-1631 |
50 | Ishihara H, Nemoto Y, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Hashimoto Y, Takagi T, Ishida H, Kondo T, Tanabe K | 2022/7 | Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up. | Jpn J Clin Oncol | | 52(7):785-790 |
51 | Yuki Nemoto· Hiroki Ishihara · Kazutaka Nakamura · Hidekazu Tachibana · Hironori Fukuda · Kazuhiko Yoshida · Hirohito Kobayashi · Junpei Iizuka · Hiroaki Shimmura · Yasunobu Hashimoto · Kazunari Tanabe · Tsunenori Kondo · Toshio Takagi | 2022/7 | Efficacy and Safety of Immunotherapy‐Based Combinations as First‐Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria | Targeted Oncology | | 17, 475–482 (2022). |
52 | Hiroki Ishihara 1, Yuki Nemoto 2, Hidekazu Tachibana 1, Hironori Fukuda 3, Kazuhiko Yoshida 3, Hirohito Kobayashi 1, Junpei Iizuka 3, Yasunobu Hashimoto 2, Toshio Takagi 3, Hideki Ishida 3, Tsunenori Kondo 1, Kazunari Tanabe 3 | 2022/7 | Outcomes of nivolumab monotherapy for previously treated metastatic renal cell carcinoma: a real-world multi-institution data with a minimum of 2 years of follow-up | Jpn J Clin Oncol | | 52(7):777-782 |
53 | Ishiyama Y | 2022/7 | Editorial Comment to Impact of early postoperative creatinine increase on mid-term renal function after cystectomy | Int J Urol | | |
54 | 服部元史*, 石塚喜世伸, 三浦健一郎, 白井陽子†, 安藤太郎, 田邉一成, 神澤太一, 石田英樹 | 2022/08 | 二次生体腎移植により生活の質の改善を得られた口顔指症候群の1例 | 日本小児腎不全学会雑誌 | | 42:163-165 |
55 | 神澤太一†, 田邉一成 | 2022/08 | 腎動脈瘤に対する外科的治療経験 | 腎移植・血管外科 | | 33(1):21-26 |
56 | Ishihara H, Ishiyama Y, Nemoto Y, Nakamura K, Tachibana H, Fukuda H, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2022/8 | Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors. | Clin Genitourin Cancer | | S1558-7673(22)00169-0 |
57 | 吉田 一彦 | 2022/8 | 各領域における分子標的薬の役割(4)臨床 3:泌尿器科領域における分子標的薬の役割 ―腎細胞癌の薬物療法を中心に― | 東女医大誌 | | 92(4) 119-125, 2022.8 |
58 | KANETSUNA Yukiko†, TANABE Kazunari, HATTORI Motoshi, NITTA Kosaku, MORIYAMA Takahito, HORITA Shigeru, YAMAGUCHI Yutaka | 2022/09 | Central fibrous areas: changes in glomerular vascular pole lesions associated with age and disease. | International urology and nephrology | Int Urol Nephrol | 54(9):2263-2273 |
59 | Hiroki Ishihara 1, Tsunenori Kondo 1, Toshio Takagi 2 | 2022/9 | Editorial Comment from Dr Ishihara et al. to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high-volume center | Int J Urol | | 29(9):993-994 |
60 | 巴 ひかる | 2022/9 | 【講演Ⅱ】頻尿と尿失禁の治療 | 公益財団法人 日本国際医学協会誌 | | (513):3-4 |
61 | 高木敏男 | 2022/9 | ロボット支援腹腔鏡下根治的腎摘除術ー後腹膜アプローチ | 泌尿器外科 | | 35 (9): 968-971 |
62 | 古澤美由紀†, 石田英樹, 神澤太一, 八木澤隆史, 石井晃太, 海上耕平, 尾本和也, 飯塚淳平, 田邉一成, 高木敏男 | 2022/10 | 腎移植患者におけるSARS-CoV-2 mRNAワクチン接種後の抗体反応についての研究(第1報) | 移植 | | 57(2):141-151 |
63 | Ishiyama Y, Kondo T, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/10 | Efficacy and feasibility of robot-assisted partial nephrectomy for octogenarians: comparison with younger counterparts. | J Robot Surg | | 16(5):1165-1173 |
64 | Yoshino M, Ishihara H, Nemoto Y, Nakamura K, Nishimura K, Tachibana H, Fukuda H, Toki D, Yoshida K, Kobayashi H, Iizuka J, Shimmura H, Hashimoto Y, Tanabe K, Kondo T, Takagi T | 2022/10 | Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. | Jpn J Clin Oncol | | 52(10):1208-1214 |
65 | Ishihara H, Fukuda H, Yoshida K, Hashimoto Y, Kondo T, Takagi T | 2022/11 | Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma. | Int J Urol | | Epub ahead of print |
66 | Yoshida K, Kobari Y, Iizuka J, Kondo T, Ishida H, Tanabe K, Takagi T | 2022/11 | Robot-assisted laparoscopic versus open partial nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease. | Int J Urol | | 29(11):1349-1355 |
67 | Takagi T, Yoshida K, Fukuda H, Kobari Y, Iizuka J. | 2022/11/29 | Analyses of operative time according to procedure phases during robot-assisted laparoscopic partial nephrectomy using the iPhone application "My Intuitives". | Int J Urol | | 2022 Nov;29(11): 1381-1385. |
68 | 尾本和也†*, 海上耕平, 神澤太一, 乾政志, 田邉一成, 高木敏男, 石田英樹 | 2022/12 | 腎移植後腎性貧血に対するHIF-PH阻害薬の使用経験 | 日本臨床腎移植学会雑誌 | 日臨腎移植会誌 | 10(2):201-208 |
69 | 海上耕平†*, 尾本和也, 大木里花子, 高木敏男, 石田英樹 | 2022/12 | 腎移植後患者とSARS-CoV-2ワクチン | 日本臨床腎移植学会雑誌 | 日臨腎移植会誌 | 10(2):148-154 |
70 | 笹野まゆ†*, 石塚敏, 小林悠梨, 安尾美年子, 三浦ひとみ, 岩藤和広, 江川裕人, 石田英樹 | 2022/12 | ABO血液型不適合生体腎移植における抗血液型IgG抗体検出法の開発 | 日本臨床腎移植学会雑誌 | 日臨腎移植会誌 | 10(2):274-282 |
71 | 矢代麻友佳†,関敦子*,高木敏男,鬼塚裕美,増井憲太,山本智子,長嶋洋治 | 2022/12 | ロボット支援腎部分切除術を施行された腎類上皮性血管筋脂肪腫の3例 | 診断病理 | | in press |
72 | 近藤恒徳 | 2022/12 | ロボット腎部分切除における高難度腫瘍に対する腎機能を意識した切除について | 日本ミニマム創泌尿器内視鏡外科学会雑誌 | | 14:71-77 |
73 | Ishiyama Y, Kondo T, Tachibana H, Yoshida K, Iizuka J, Tanabe K, Takagi T | 2022/12 | Impact of Warm Ischemia on Acute Kidney Injury After Robotic Partial Nephrectomy Stratified by Baseline Kidney Function. | J Endourol | | Epub ahead of print |
74 | Toshihito Hirai, Po-Yu Lin, Teresa L Ramos, Federico Simonetta, Leon L Su, Lora K Picton, Jeanette Baker, Juliane K Lohmeyer, K Christopher Garcia, Robert S Negrin. | 2022/12 | IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor. | American Journal of Transplantation | Am J Transplant | 22(12):3061-3068. (PMID 36031344) |
75 | Teresa Lopes Ramos, Sara Bolivar-Wagers, Sujeong Jin, Govindarajan Thangavelu, Federico Simonetta, Po-Yu Lin, Toshihito Hirai, Asim Saha, Brent H Koehn, Leon L Su, Lora K Picton, Jeanette Baker, Juliane K Lohmeyer, Megan J Riddle, Cindy Eide, Jakub Tolar, Angela Panoskaltsis-Mortari, John E Wagner, K Christopher Garcia, Robert S Negrin, Bruce R Blazar. | 2022/12 | Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo. | Blood | Blood | 23;blood.2022018440. (PMID 36564052) |
76 | Juliane K Lohmeyer, Toshihito Hirai, Mustafa Turkoz, Stephane Buhler, Teresa Lopes Ramos, Natalie Köhler, Jeanette Baker, Astrid Melotti, Ingrid Wagner, Amandine Pradier, Sisi Wang, Xuhuai Ji, Simone Becattini, Jean Villard,
Doron Merkler, Yves Chalandon, Robert S Negrin, Federico Simonetta. | 2022/12 | Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD. | Blood | Blood | 27;blood.2022017982. (PMID 36574344) |
77 | 根本侑樹、萩原鮎夢、坂本鉄志、柴山隆宏、佐藤英章、山崎早苗、橋本恭伸 | 2022 | 当院における限局性前立腺癌に対する術式別周術期成績の比較検討 | 埼玉県医学会雑誌 | | 57(1): 333-339 |